Oral, Injected Semaglutide May Pose Distinct Eye Risks
The risk for ocular problems linked to different formulations of semaglutide appear to vary, according to a new study, which also identified differences based on sex, age, and timing of onset. Medscape Medical News
Podcast: How to Control the Side Effects of GLP-1 Drugs
Can “Ozempic face,” gastrointestinal distress, and nausea be mitigated? This episode features audio from https://nutritionfacts.org/video/how-to-control-the-side-effects-including-ozempic-face-of-glp-1-drugs/ Visit the video page for all sources and doctor’s notes related to this podcast. https://NutritionFacts.org • Subscribe: https://nutritionfacts.org/subscribe • Donate: https://nutritionfacts.org/donate • Podcast : https://nutritionfacts.org/audio • Books: https://nutritionfacts.org/books • Shop: https://drgreger.org • Facebook: https://www.facebook.com/NutritionFacts.org • Twitter: https://twitter.com/nutrition_facts • Instagram: https://www.instagram.com/nutrition_facts_org
CVS to boost access to Novo Nordisk’s weight loss treatment Wegovy for patients on its drug plans – CNBC
CVS to boost access to Novo Nordisk’s weight loss treatment Wegovy for patients on its drug plans CNBC Novo Nordisk announces that CVS Caremark®, the country’s largest PBM, has decided Wegovy® will be the preferred GLP-1 medicine covered for obesity on its template formularies PR Newswire Eli Lilly shares fall as competitor Novo notches coverage win for […]
Can weight loss drugs prevent breast cancer recurrence?
Researchers in Dallas want to know if the class of drugs, GIP/GLP-1 receptor agonists, might be a secret weapon in the fight against breast cancer.
Semaglutide effectively treats liver disease in two thirds of patients, research finds
Results from the ESSENCE Phase III clinical trial published in the New England Journal of Medicine show treating patients with semaglutide can halt and even reverse liver disease.
Many Medicaid Enrollees Have Restricted Access to SGLT2 Inhibitors, GLP-1 Receptor Agonists
WEDNESDAY, April 30, 2025 — Many Medicaid enrollees with type 2 diabetes have restricted access to cardioprotective medications, including sodium-glucose cotransporter-2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1…
Can Oral Formulations of Biologics Work?
Although biologics are usually given by injection or intravenous infusion, oral formulations might be possible. In general, oral drugs offer many benefits, from simplified distribution to overall cost reductions for patients, as well as being easier use and often have better patient compliance. Nonetheless, acids and enzymes in the stomach can degrade biologics even before […]
Metformin, in a 7-day trial, blocked prednisone-induced insulin resistance by raising GLP-1, blunting insulin secretion, and downregulating lipid metabolism genes. It also showed signs of protecting muscle and bone, suggesting broader metabolic benefits.
submitted by /u/bevatsulfieten [link] [comments]
Weight loss drugs can help employers cut health care costs, study says
Covering the cost of pricey GLP-1 weight loss drugs could pay off for employers by cutting overall medical spending for people taking the medications, but not until year two, according to a massive analysis of health insurance claims by Aon released on Wednesday. Read more…
Humbi AI by Innovaccer and Landmark Science to Present Real-World Evidence on GLP-1 Use for Cardiometabolic and Cardiovascular Risk Reduction in Medicare Populations at ISPOR 2025
MONTREAL–(BUSINESS WIRE)–Innovaccer, the leading healthcare AI company, today announced that its recently acquired actuarial science company – Humbi AI, in collaboration with Landmark Science, Inc., will present a joint research at the upcoming International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2025 annual conference, scheduled to take place between May 13–16 in Montreal, QC, Canada. […]